Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Fuso Pharmaceutical Industries,Ltd. ( (JP:4538) ) has issued an update.
Fuso Pharmaceutical Industries, Ltd. has announced its medium-term management plan, FUSO VISION 2030 Next Stage, aimed at addressing industry challenges and ensuring sustainable growth. The plan includes significant investments in production facilities, research and development, and digital transformation to enhance corporate value and meet unmet medical needs. The company aims to achieve sales of over 70 billion yen and an ROE of over 8.0% by 2030, despite expected profit declines until 2028 due to initial investments.
More about Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries, Ltd. operates in the pharmaceutical industry, focusing on the production of basic pharmaceutical products. The company prioritizes the stable supply of medicines essential for healthcare, with a market focus on dialysis supplies, kidney and urinary system products, and infertility treatment solutions.
Average Trading Volume: 17,054
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen19.61B
See more data about 4538 stock on TipRanks’ Stock Analysis page.